A. Frampton

发表

The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells

M. White, A. Frampton, 2013, Cancer Gene Therapy.

Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection.

J. Glorioso, A. Ozuer, W. Goins, 2007, Virology.

Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells.

P. Grandi, J. von Einem, J. Glorioso, 2010, Veterinary microbiology.

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

Dinh Q. Phung, C. A. Shaw, M. Kumar, 2021, The Lancet Oncology.

Equus caballus Major Histocompatibility Complex Class I Is an Entry Receptor for Equine Herpesvirus Type 1

S. Kelly, A. Frampton, Brian M Kurtz, 2010, Journal of Virology.

Therapeutic Gene Transfer with Replication-Defective Herpes Simplex Viral Vectors

J. Glorioso, D. Fink, M. Mata, 2008 .

Equine herpesvirus type 1 modulates inflammatory host immune response genes in equine endothelial cells.

A. Frampton, S. Johnstone, Jekaterina Barsova, 2016, Veterinary microbiology.

Equine Herpesvirus 1 Enters Cells by Two Different Pathways, and Infection Requires the Activation of the Cellular Kinase ROCK1

D. Stolz, J. Glorioso, W. Goins, 2007, Journal of Virology.

HSV trafficking and development of gene therapy vectors with applications in the nervous system

K. Nakano, J. Glorioso, W. Goins, 2005, Gene Therapy.

Equine Herpesvirus Type 1-Mediated Oncolysis of Human Glioblastoma Multiforme Cells

Brent A. Stanfield, M. White, A. Frampton, 2011, Journal of Virology.

Equine Herpesvirus 1 Utilizes a Novel Herpesvirus Entry Receptor

J. von Einem, J. Glorioso, N. Osterrieder, 2005, Journal of Virology.

Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model.

Patrick M. Smith, N. Osterrieder, T. Matsumura, 2002, Virus research.

Third International Havemeyer Workshop on Equine Herpesvirus type 1.

D. Antczak, G. R. Van de Walle, H. Nauwynck, 2012, Equine veterinary journal.

Meningoencephalitis in Mice Infected with an Equine Herpesvirus 1 Strain KyA Recombinant Expressing Glycoprotein I and Glycoprotein E

Patrick M. Smith, N. Osterrieder, T. Matsumura, 2004, Virus Genes.

Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.

Patrick M. Smith, N. Osterrieder, S. Jennings, 2003, Viral immunology.

Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells.

Lacie M. Chauvigne-́Hines, Tyler J. Goodwin, L. Bartolotti, 2017, Biochemistry.

Mechanistic Investigation of Site-specific DNA Methylating Agents Targeting Breast Cancer Cells.

L. Bartolotti, S. Varadarajan, S. Wardell, 2021, Journal of medicinal chemistry.

Generation of Herpesvirus Entry Mediator (HVEM)-Restricted Herpes Simplex Virus Type 1 Mutant Viruses: Resistance of HVEM-Expressing Cells and Identification of Mutations That Rescue Nectin-1 Recognition

P. Grandi, J. Glorioso, A. Ozuer, 2009, Journal of Virology.

Equid herpesvirus type 4 uses a restricted set of equine major histocompatibility complex class I proteins as entry receptors.

R. Harman, Donald C. Miller, D. Antczak, 2014, The Journal of general virology.

Anti-inflammatory compounds reduce equine herpesvirus type 1 replication and cell-to-cell spread

A. Frampton, Jeanette Black, 2023, Frontiers in Veterinary Science.

Detection of SARS-CoV-2 RNA in wastewater from an enclosed college campus serves as an early warning surveillance system

L. Cahoon, Ryan G. Rhodes, A. Frampton, 2023, PloS one.